|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Circulating vegf levels in the serum of gastric cancer patients:Correlation with pathological variables,patient survival,and tumor surgery显示文摘 | Karayiannakis AJ Syrigos KN Polychronidis A | 2002 | Ann Surg2002，236，： | 1 |
| 2 | Expression patterns of the novel catenin p120cas in gastrointestinal cancers显示文摘 | Karayiannakis AJ Syrigos KN Alexiou D | 1999 | Anticancer Res1999，19，5： | 1 |
| 3 | Expression patterns of alpha-,beta-and gamma-catenin in pancreatic cancer:correlation with E-cadherin expression,pathological features and prognosis显示文摘 | Karayiannakis AJ Syrigos KN Polyehronidis A | 2001 | Anticancer Res2001，21，6： | 1 |
| 4 | Circulating VEGF levels in the serum of gastric cancer patients:correlation with pathological variables, patient survival,and tumor surgery 显示文摘 | KARAYIANNAKIS AJ SYRIGOS KN POLYCHRONIDIS A | 2002 | Ann Surg2002，236，1： | 1 |
| 5 | Targeted therapy for oesophageal cancer:an overview显示文摘 | Syrigos KN Zalonis A Kotteas E | | 0，，02： | 1 |
| 6 | Novel agents and future pros- pects in the treatment of pancreatic adenarcinoma 显示文摘 | Sarris EG Syrigos KN Saif MW | 2013 | JOP2013，14，4： | 1 |
| 7 | Circu- lating VEGF levels in the serum of gastric cancer patients 显示文摘 | Karayiannakis A Syrigos KN Polychronidis A | 2002 | Ann Surg2002，236，： | 1 |
| 8 | Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery显示文摘 | Karayiannakis A J Syrigos KN Polychronidis A | 2002 | Ann Surg2002，236，1： | 1 |
| 9 | Novel agents and new combination treatments on phase Ⅰ studies on solid tumors and pancreatic cancer显示文摘 | Strimpakos AS Syrigos KN Saif MW | 2012 | JOP2012，13，4： | 1 |
| 10 | S-1:a promising new oral fluoropyrimidine derivative显示文摘 | Saif MW Syrigos KN Katirtzoglou NA | 2009 | Expert Opin Investig Drugs2009，18，3： | 1 |
| 11 | Circulating VEGF levels in the serum of gastric cancer patients:correlation with pathological variables,patient survival and tmorsurgery显示文摘 | Karayiannakis AJ Syrigos KN Polychronidis A | 2002 | Ann Surg2002，236，： | 1 |
| 12 | Clinical significance of Serum levels of E-selectin,intercellular adhesion molecule-l,and vascular cell adhesion molecule-1 in gastric cancer patients显示文摘 | Alexiou D Karayiannakis AJ Syrigos KN | 2003 | Am J Gastroenterol2003，98，2： | 1 |
| 13 | Thyroid transcriptionfactor 1 is an independent prognostic factor for patients with stage Ilung adenocarcinoma显示文摘 | Anagnostou VK Syrigos KN Bepler G | 2009 | J Clin Oncol2009，27，2： | 1 |
| 14 | Key molecular mechanisms in lung cancer invasion and metastasis:a comprehensive review显示文摘 | Perlikos F Harrington KJ Syrigos KN | 2013 | Crit Rev Oncol Hematol2013，87，1： | 1 |
| 15 | Serum levels of E-selectin,ICAM-1 and VCAM-1 in colorectal cancer patients:correlations with clinicopathological features,patieht survival and tumour surgery显示文摘 | Alexiou D Karayiannakis AJ Syrigos KN | 2001 | EurJ Cancer2001，37，18： | 1 |
| 16 | Clinical significance of8emm levels of E-seleetin,intercellular adhesion molecule-1 and vascular cell adhesiOn moleeule-1 in gastric c Ⅱ ncer patlent显示文摘 | Alexiou D Karayiannakis AJ Syrigos KN | 2003 | Am J Gastroenterol2003，98，2： | 1 |
| 17 | Thyroid tran scription factor 1 is an independent prognostic factor for patients with stage I lung adenoearcinoma 显示文摘 | Anagnostou VK Syrigos KN Bepler G | 2009 | J Clini Oncol2009，27，2： | 1 |
| 18 | The prognostic significance of autoantibodies againet dsDNA in patient with colcrectal adenocarcinoma显示文摘 | Syrigos KN Charalambopoulos A Pliarchopou K | 2000 | Anticancer Res2000，2020，： | 1 |
| 19 | Prognostic and predictive factors in a randomized phase III trial comparing cis- platin-pemetrexed versus cisplatin-gemcitabine in advanced non-small- cell lung cancer 显示文摘 | Syrigos KN Vansteenkiste J Parikh P | 2010 | Ann Oncol2010，21，3： | 1 |
| 20 | The role of EGFR inhibitors in the treatment of metastatic anal canal carcinoma:a case series显示文摘 | Saif MW Kontny E Syrigos KN | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员